Twists And Turns Ahead For Medtech In Europe As AI Dominates October Regulatory Debates

The regulation of artificial intelligence in medtech products is increasingly under the spotlight, in the EU and globally. A glance at October’s news sees a proliferation of schemes and actions to support medtech AI development in as safe and well-controlled an environment as possible.

AI Regulation
• Source: Shutterstock

Artifical Intelligence (AI) complicates the regulation and oversight of medtech products. And it is not the only new area of technology that is overlapping with medical devices and IVDs in the EU. Other horizontal existing and proposed regulations, namely the General Data Protection Regulation (GDPR), the AI Liability Directive, the Cyber Resilience Act, the Data Act, the Data Governance Act, the European Health Data Space Regulation (EHDS) and the revised Product Liability Directive are all adding to what many in the sector now describe as a “regulatory lasagna”.

To address this increasingly complex environment regulatory sandboxes are increasingly being suggested as a safe space for regulators, industry...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

Questions Over UK Prevention Agenda Within NHS 10-Year Plan

 
• By 

The UK government’s blueprint to deliver an NHS "fit for the future" was released on July 3.

June 2025: A Bumper Month For New EU Medtech Documents And Initiatives

 

The rate at which new documents to support the implementation of EU medtech regulations are issued has slowed of late; but June bucked the trend, with a flurry of activity.

NICE’s Rules-Based Pathway And Innovator Passports Get Go-Ahead In UK NHS 10-Year Plan

 
• By 

The NHS 10-Year Plan officially released on July 3 will crystalize NICE’s Rules-Based Pathway – a new concept for medtech evaluation that will come with a guarantee of funding – but only for a select number of products. Government to also introduce “innovator passport” to speed innovation into NHS.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.

More from Geography

NICE’s Rules-Based Pathway And Innovator Passports Get Go-Ahead In UK NHS 10-Year Plan

 
• By 

The NHS 10-Year Plan officially released on July 3 will crystalize NICE’s Rules-Based Pathway – a new concept for medtech evaluation that will come with a guarantee of funding – but only for a select number of products. Government to also introduce “innovator passport” to speed innovation into NHS.

New Draft Guidance Clarifies FDA’s UDI Rules For Combination Products

 
• By 

The FDA has released draft guidance clarifying UDI rules for drug- and device-led combination products. The document specifies labeling requirements and makes recommendations to reduce confusion between UDIs and NDCs. Comments are being accepted until Sept. 24.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.